Maxims applied: Genentech rewrites medical marketing rules with Heceptin® and personalized medicine

  1916      Nov 30, -0001
I hope you enjoy this week's Maxim on how Genentech rewrote the rules of drug marketing. It is a delightful weave of science, statistics, and marketing. -- Dan So you’re in marketing? What would your management do if they found out you had passed up an opportunity to gain millions of impressions – many with the top managements of your customers – for free? Shouldn’t you be posting your releases and white papers at Transform Your Presentations & White Papers into Global Promotional Tools! Webprint at All you have to do is sign-up for a free membership and then you can post what you want. Go gain access to thousands of readers – many in top management – and it doesn’t cost you a penny. weSRCH: Hits per Month: 5.6 million Page Views per Month*: 2.7 million Readers (unique visitors): 85 thousand Pages Read Per Person*: 39 Average Income: 144 thousand Regional Distribution: * Multi-page PDF’s counted as 1 page. Since most papers are multi-page PDFs, these numbers are conservative.
About weVISION: weQuest's are written by G Dan Hutcheson, his career spans more than thirty years, in which he became a well-known as a visionary for helping companies make businesses out of technology. This includes hundreds of successful programs involving product development, positioning, and launch in Semiconductor, Technology, Medicine, Energy, Business, High Tech, Enviorntment, Electronics, healthcare and Business devisions.

You may like this also:

Yoojin Oh
20 September, 2019
19 September, 2019
18 September, 2019
17 September, 2019

IMAP Medical Devices

Here describe the IMAP’s experience in healthcare buy-side advisory and deep knowledge of the industry were key factors in successfully closing the transaction.

16 September, 2019
15 September, 2019
ISMP Canada
13 September, 2019
12 September, 2019

Recent weVISIONs

Open IC Design Platforms ... with Michael Wishart of Efabless
Michael WishartEfabless
20 August, 2019
Tom Caulfield on what's next at GLOBALFOUNDRIES
22 July, 2019